Source: School Course 2012 - Lung Transplantation



Rating:

Share or cite this content

Citations should be made in the following way:
A. Boehler (Zurich, Switzerland). Old and new therapeutic options in BOS. School Course 2012 - Lung Transplantation

Member's Comments

No comment yet.

Related content which might interest you: New therapeutic strategies in BOS Source: Annual Congress 2007 - Bronchiolitis obliterans syndrome (BOS) after lung transplantation: new kids on the block Year: 2007 Old and new strategies in induction therapy Source: School Course 2012 - Lung Transplantation Year: 2012 Bronchiectasis: new therapies and perspectives Source: International Congress 2018 – Bronchiectasis: new insights in diagnosis and treatment Year: 2018 Clinical implications and opportunities for new drug therapies Source: Annual Congress 2008 - Deadly networks: disease-causing protein and DNA modifications Year: 2008 Recommended new therapies for severe asthma and the future Source: International Congress 2014 – PG05 Severe asthma – highlights from the ERS/ATS workshop Year: 2014 Recommendations of new therapies for severe asthma and the future Source: Annual Congress 2013 –ERS/ATS Task Force report on severe asthma Year: 2013 Novel targets and emerging therapies in MPM Source: ERS Skills course: Multi-disciplinary care in thoracic oncology Year: 2019 A pragmatic guide to choosing biologic therapies in severe asthma Source: Breathe, 17 (4) 210144; 10.1183/20734735.0144-2021 Year: 2021 Current and future preventive and treatment strategies in CLAD Source: International Congress 2015 – When chronic inflammation drives fibrosis: a lesson from lung transplantation Year: 2015 Clinical implications and novel therapies Source: International Congress 2018 – Accelerated ageing in lungs Year: 2018 HAP/VAP : new guidelines, new approaches Source: International Congress 2018 – Chinese Programme 2018: Part II Year: 2018 COVID-19 conundrum: clinical phenotyping based on pathophysiology as a promising approach to guide therapy in a novel illness Source: Eur Respir J, 56 (2) 2002135; 10.1183/13993003.02135-2020 Year: 2020 Alternative immunosuppressive strategies Source: ERS Course 2016 Year: 2016 Facts and perspectives in the development of new anti-TB drugs Source: Annual Congress 2008 - New insights into tuberculosis control Year: 2008 Bronchiectasis: state-of-the-art diagnostic and therapeutic approaches Source: Virtual Congress 2021 – Respiratory infections Year: 2021